Vliv predoperační radiochemoterapie na expresi vaskulárního endoteliálního růstového faktoru a hustoty CD8+ tumor infiltrujících lymfocytů adenokarcinomu rekta

Rectum adenocarcinoma is one of the most frequent tumour diseases in the Czech Republic. Therefore any progress in therapy or prevention of this disease can have a significant impact on mortality and morbidity of major amount of oncological patients. Within therapy the neoadjuvant concomitant radioc...

Full description

Bibliographic Details
Main Author: Buka, David
Other Authors: Petera, Jiří
Format: Doctoral Thesis
Language:Czech
Published: 2021
Online Access:http://www.nusl.cz/ntk/nusl-448436
id ndltd-nusl.cz-oai-invenio.nusl.cz-448436
record_format oai_dc
spelling ndltd-nusl.cz-oai-invenio.nusl.cz-4484362021-07-26T05:10:12Z Vliv predoperační radiochemoterapie na expresi vaskulárního endoteliálního růstového faktoru a hustoty CD8+ tumor infiltrujících lymfocytů adenokarcinomu rekta The Changes of the Tumor Vascular Endothelial Growth Factor Expression and the Density CD8+ Tumor Infiltrating Lymphocytes after Neoadjuvant Chemoradiation in Patients with Rectal Adenocarcinoma Buka, David Petera, Jiří Vrána, David Mohelníková Duchoňová, Beatrice Rectum adenocarcinoma is one of the most frequent tumour diseases in the Czech Republic. Therefore any progress in therapy or prevention of this disease can have a significant impact on mortality and morbidity of major amount of oncological patients. Within therapy the neoadjuvant concomitant radiochemotherapy or the sole radiotherapy is used before surgical resection in one third to half of all newly diagnosed cases. The goal is to achieve tumor downstaging and local relaps probability decrease. There is a large amount of processes on molecular and cellular level in organism reaction to neoplasia genesis, whose understanding can have a substantial impact on therapy's success rate or on therapy's efficiency prediction. One of these processes is angiogenesis induced by high production of vascular endothelial growth factor (VEGF). As per immunohistochemical studies VEGF is not expressed in typical colorectum mucous membrane. However it is strongly expressed in case of adenocarcinoma. Another important process of organism's malignancy response is tumour tissue infiltration by CD8+ T lymphocytes (TIL), which are one of the important components of cellular immunity against tumour and which significantly contribute to tumour cells elimination. Potential of CD8+ T lymphocytes is considerable not just in... 2021 info:eu-repo/semantics/doctoralThesis http://www.nusl.cz/ntk/nusl-448436 cze info:eu-repo/semantics/restrictedAccess
collection NDLTD
language Czech
format Doctoral Thesis
sources NDLTD
description Rectum adenocarcinoma is one of the most frequent tumour diseases in the Czech Republic. Therefore any progress in therapy or prevention of this disease can have a significant impact on mortality and morbidity of major amount of oncological patients. Within therapy the neoadjuvant concomitant radiochemotherapy or the sole radiotherapy is used before surgical resection in one third to half of all newly diagnosed cases. The goal is to achieve tumor downstaging and local relaps probability decrease. There is a large amount of processes on molecular and cellular level in organism reaction to neoplasia genesis, whose understanding can have a substantial impact on therapy's success rate or on therapy's efficiency prediction. One of these processes is angiogenesis induced by high production of vascular endothelial growth factor (VEGF). As per immunohistochemical studies VEGF is not expressed in typical colorectum mucous membrane. However it is strongly expressed in case of adenocarcinoma. Another important process of organism's malignancy response is tumour tissue infiltration by CD8+ T lymphocytes (TIL), which are one of the important components of cellular immunity against tumour and which significantly contribute to tumour cells elimination. Potential of CD8+ T lymphocytes is considerable not just in...
author2 Petera, Jiří
author_facet Petera, Jiří
Buka, David
author Buka, David
spellingShingle Buka, David
Vliv predoperační radiochemoterapie na expresi vaskulárního endoteliálního růstového faktoru a hustoty CD8+ tumor infiltrujících lymfocytů adenokarcinomu rekta
author_sort Buka, David
title Vliv predoperační radiochemoterapie na expresi vaskulárního endoteliálního růstového faktoru a hustoty CD8+ tumor infiltrujících lymfocytů adenokarcinomu rekta
title_short Vliv predoperační radiochemoterapie na expresi vaskulárního endoteliálního růstového faktoru a hustoty CD8+ tumor infiltrujících lymfocytů adenokarcinomu rekta
title_full Vliv predoperační radiochemoterapie na expresi vaskulárního endoteliálního růstového faktoru a hustoty CD8+ tumor infiltrujících lymfocytů adenokarcinomu rekta
title_fullStr Vliv predoperační radiochemoterapie na expresi vaskulárního endoteliálního růstového faktoru a hustoty CD8+ tumor infiltrujících lymfocytů adenokarcinomu rekta
title_full_unstemmed Vliv predoperační radiochemoterapie na expresi vaskulárního endoteliálního růstového faktoru a hustoty CD8+ tumor infiltrujících lymfocytů adenokarcinomu rekta
title_sort vliv predoperační radiochemoterapie na expresi vaskulárního endoteliálního růstového faktoru a hustoty cd8+ tumor infiltrujících lymfocytů adenokarcinomu rekta
publishDate 2021
url http://www.nusl.cz/ntk/nusl-448436
work_keys_str_mv AT bukadavid vlivpredoperacniradiochemoterapienaexpresivaskularnihoendotelialnihorustovehofaktoruahustotycd8tumorinfiltrujicichlymfocytuadenokarcinomurekta
AT bukadavid thechangesofthetumorvascularendothelialgrowthfactorexpressionandthedensitycd8tumorinfiltratinglymphocytesafterneoadjuvantchemoradiationinpatientswithrectaladenocarcinoma
_version_ 1719417924589977600